Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
5.15
-0.02 (-0.39%)
After-hours: Apr 28, 2026, 6:57 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $13.13 million as of April 28, 2026. Its market cap has decreased by -55.40% in one year.
Market Cap
13.13M
Enterprise Value
1.32M
1-Year Change
-55.40%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $13.13M, a decrease of -80.10%. That is a compound annual growth rate of -43.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.29M | -46.07% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 15.09M |
| Hoth Therapeutics | 14.92M |
| Soligenix | 14.58M |
| Phio Pharmaceuticals | 14.06M |
| Moleculin Biotech | 13.55M |
| Jupiter Neurosciences | 13.16M |
| Kairos Pharma | 12.83M |
| BioCardia | 12.69M |